228 related articles for article (PubMed ID: 30055601)
1. Corruption practices in drug prescribing in Vietnam - an analysis based on qualitative interviews.
Nguyen TA; Knight R; Mant A; Razee H; Brooks G; Dang TH; Roughead EE
BMC Health Serv Res; 2018 Jul; 18(1):587. PubMed ID: 30055601
[TBL] [Abstract][Full Text] [Related]
2. Inflated medicine prices in Vietnam: a qualitative study.
Nguyen TA; Knight R; Mant A; Razee H; Brooks G; Dang TH; Roughead EE
Health Policy Plan; 2017 Jun; 32(5):647-656. PubMed ID: 28453716
[TBL] [Abstract][Full Text] [Related]
3. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
[TBL] [Abstract][Full Text] [Related]
4. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
[TBL] [Abstract][Full Text] [Related]
5. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
McCarthy M
BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
[No Abstract] [Full Text] [Related]
6. Experts' agency problems: evidence from the prescription drug market in Japan.
Iizuka T
Rand J Econ; 2007; 38(3):844-62. PubMed ID: 18478669
[TBL] [Abstract][Full Text] [Related]
7. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
[TBL] [Abstract][Full Text] [Related]
8. Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing.
Qian J; Hansen RA; Surry D; Howard J; Kiptanui Z; Harris I
Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):819-826. PubMed ID: 28485111
[TBL] [Abstract][Full Text] [Related]
9. Students and Doctors are Unaware of the Cost of Drugs they Frequently Prescribe.
Schutte T; Tichelaar J; Nanayakkara P; Richir M; van Agtmael M
Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):278-283. PubMed ID: 27639184
[TBL] [Abstract][Full Text] [Related]
10. Understanding profit margins of medical providers from prescription drugs: evidence from Taiwan.
Liu YM
Int Health; 2020 Jul; 12(4):272-280. PubMed ID: 31647555
[TBL] [Abstract][Full Text] [Related]
11. Corruption in Anglophone West Africa health systems: a systematic review of its different variants and the factors that sustain them.
Onwujekwe O; Agwu P; Orjiakor C; McKee M; Hutchinson E; Mbachu C; Odii A; Ogbozor P; Obi U; Ichoku H; Balabanova D
Health Policy Plan; 2019 Sep; 34(7):529-543. PubMed ID: 31377775
[TBL] [Abstract][Full Text] [Related]
12. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
13. Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the practices?
Mohiuddin M; Rashid SF; Shuvro MI; Nahar N; Ahmed SM
BMC Med Ethics; 2015 Dec; 16(1):80. PubMed ID: 26625723
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
[TBL] [Abstract][Full Text] [Related]
15. "It Keeps Us from Putting Drugs in Pockets": How a Public-Private Partnership for Hospital Management May Help Curb Corruption.
Vian T; Mcintosh N; Grabowski A
Perm J; 2017; 21():16-113. PubMed ID: 28746025
[TBL] [Abstract][Full Text] [Related]
16. The UK pharmaceutical market. An overview.
Towse A
Pharmacoeconomics; 1996; 10 Suppl 2():14-25. PubMed ID: 10163432
[TBL] [Abstract][Full Text] [Related]
17. Towards rational prescribing.
Gilley J
BMJ; 1994 Mar; 308(6931):731-2. PubMed ID: 8142822
[No Abstract] [Full Text] [Related]
18. Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.
Wladysiuk M; Araszkiewicz A; Godman B; Szabert K; Barbui C; Haycox A
Appl Health Econ Health Policy; 2011 Mar; 9(2):101-10. PubMed ID: 21271749
[TBL] [Abstract][Full Text] [Related]
19. US drug marketing: how does promotion correspond with health value?
Greenway T; Ross JS
BMJ; 2017 May; 357():j1855. PubMed ID: 28465309
[No Abstract] [Full Text] [Related]
20. Doctors and drug companies: still cozy after all these years.
Henry D
PLoS Med; 2010 Nov; 7(11):e1000359. PubMed ID: 21072244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
